S-allylcysteine induces cell cycle arrest and apoptosis in androgen-independent human prostate cancer cells

Molecular Medicine Reports

Volumn 5, Issue 2, 2012, Pages 439-443

  Liu, Zhuo ^a   Li, Mingchao ^a   Chen, Ke ^a   Yang, Jun ^a   Chen, Ruibao ^a   Wang, Tao ^a   Liu, Jihong ^a   Yang, Weimin ^a   Ye, Zhangqun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; PC 3 cells; Proliferation; Prostate cancer; S allylcysteine

Indexed keywords

CASPASE 8; PROTEIN BAX; PROTEIN BCL 2; S ALLYLCYSTEINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SCREENING; HUMAN; HUMAN CELL; MALE; PROSTATE CANCER; PROTEIN EXPRESSION;

ANDROGENS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 8; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CYSTEINE; GARLIC; HUMANS; MALE; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2;

ALLIUM SATIVUM;

EID: 84862908107     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.658     Document Type: Article

References (34)

1. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
2. Song F, He M, Li H, et al: A cancer incidence survey in Tianjin: the third largest city in China between 1981 and 2000. Cancer Causes Control 19: 443-450, 2008.
3. So A, Gleave M, Hurtado-Col A and Nelson C: Mechanisms of the development of androgen independence in prostate cancer. World J Urol 23: 1-9, 2005. (Pubitemid 40425164)
4. Mohla S, Stearns V, Sathyamoorthy N, Rosenfeld MG and Nelson P: The biology of hormone refractory breast and prostate cancer: an NCI workshop report. Cancer Biol Ther 8: 1975-1985, 2009.
5. Bhandari MS, Petrylak DP and Hussain M: Clinical trials in metastatic prostate cancer - has there been real progress in the past decade? Eur J Cancer 41: 941-953, 2005. (Pubitemid 40461694)
6. Lim DY, Tyner AL, Park JB, Lee JY, Choi YH and Park JH: Inhibition of colon cancer cell proliferation by the dietary compound conjugated linoleic acid is mediated by the CDK inhibitor p21CIP1/WAF1. J Cell Physiol 205: 107-113, 2005. (Pubitemid 41262856)
7. Sliva D, Jedinak A, Kawasaki J, Harvey K and Slivova V: Phellinus linteus suppresses growth, angiogenesis and invasive behaviour of breast cancer cells through the inhibition of AKT signalling. Br J Cancer 98: 1348-1356, 2008. (Pubitemid 351543583)
8. Rivlin RS: Historical perspective on the use of garlic. J Nutr 131: S951-S954, 2001.
9. Park JH, Park YK and Park E: Antioxidative and antigenotoxic effects of garlic (Allium sativum L.) prepared by different processing methods. Plant Foods Hum Nutr 64: 244-249, 2009.
10. Ulbricht C, Chao W, Costa D, Rusie-Seamon E, Weissner W and Woods J: Clinical evidence of herb-drug interactions: a systematic review by the natural standard research collaboration. Curr Drug Metab 9: 1063-1120, 2008.
11. Asdaq SM and Inamdar MN: Potential of garlic and its active constituent, S-allylcysteine, as antihypertensive and cardioprotective in presence of captopril. Phytomedicine 17: 1016-1026, 2010.
12. Lee Y, Kim H, Lee J and Kim K: Anticancer activity of S-allylmercapto-L-cysteine on implanted tumor of human gastric cancer cell. Biol Pharm Bull 34: 677-681, 2011.
13. Tang FY, Chiang EP and Pai MH: Consumption of S-allylcysteine inhibits the growth of human non-small-cell lung carcinoma in a mouse xenograft model. J Agric Food Chem: Sept, 2010 (E-pub ahead of print).
14. Malki A, El-Saadani M and Sultan AS: Garlic constituent diallyl trisulfide induced apoptosis in MCF7 human breast cancer cells. Cancer Biol Ther 8: 2175-2185, 2009.
15. Cruz C, Correa-Rotter R, Sanchez-Gonzalez DJ, et al: Renoprotective and antihypertensive effects of S-allylcysteine in 5/6 nephrectomized rats. Am J Physiol Renal Physiol 293: F1691-F1698, 2007. (Pubitemid 350086006)
16. Katsuki T, Hirata K, Ishikawa H, Matsuura N, Sumi S and Itoh H: Aged garlic extract has chemopreventative effects on 1,2-dimethylhydrazine-induced colon tumors in rats. J Nutr 136: S847-S851, 2006.
17. Chu Q, Ling MT, Feng H, et al: A novel anticancer effect of garlic derivatives: inhibition of cancer cell invasion through restoration of E-cadherin expression. Carcinogenesis 27: 2180-2189, 2006. (Pubitemid 44644806)
18. Chu Q, Lee DT, Tsao SW, Wang X and Wong YC: S-allylcysteine, a water-soluble garlic derivative, suppresses the growth of a human androgen-independent prostate cancer xenograft, CWR22R, under in vivo conditions. BJU Int 99: 925-932, 2007. (Pubitemid 46439548)
19. Lapenna S and Giordano A: Cell cycle kinases as therapeutic targets for cancer. Nat Rev Drug Discov 8: 547-566, 2009.
20. Malumbres M and Barbacid M: Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9: 153-166, 2009.
21. Caldon CE, Sutherland RL and Musgrove E: Cell cycle proteins in epithelial cell differentiation: implications for breast cancer. Cell Cycle 9: 1918-1928, 2010.
22. Zhang K, Wu J, Wu X, et al: p53R2 inhibits the proliferation of human cancer cells in association with cell-cycle arrest. Mol Cancer Ther 10: 269-278, 2011.
23. Brooke GN, Culley RL, Dart DA, et al: FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growth. Cancer Res 71: 914-924, 2011.
24. Li B, Shi XB, Nori D, et al: Down-regulation of microRNA 106b is involved in p21-mediated cell cycle arrest in response to radiation in prostate cancer cells. Prostate 71: 567-574, 2011.
25. Heinlein CA and Chang C: Androgen receptor in prostate cancer. Endocr Rev 25: 276-308, 2004. (Pubitemid 38501396)
26. Balk SP and Knudsen KE: AR, the cell cycle, and prostate cancer. Nucl Recept Signal 6: e001, 2008.
27. Debes JD and Tindall DJ: Mechanisms of androgen-refractory prostate cancer. N Engl J Med 351: 1488-1490, 2004. (Pubitemid 39315314)
28. Velmurugan B, Mani A and Nagini S: Combination of S-allylcysteine and lycopene induces apoptosis by modulating Bcl-2, Bax, Bim and caspases during experimental gastric carcinogenesis. Eur J Cancer Prev 14: 387-393, 2005. (Pubitemid 41104948)
29. Llambi F and Green DR: Apoptosis and oncogenesis: give and take in the BCL-2 family. Curr Opin Genet Dev 21: 12-20, 2011.
30. Tait SW and Green DR: Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11: 621-632, 2010.
31. Taylor RC, Cullen SP and Martin SJ: Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 9: 231-241, 2008. (Pubitemid 351301823)
32. Reed JC: Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities. Cell Death Differ 13: 1378-1386, 2006.
33. Chipuk JE and Green DR: How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol 18: 157-164, 2008.
34. Knudson CM and Brown NM: Mitochondria potential, bax 'activation' and programmed cell death. Methods Mol Biol 414: 95-108, 2008.